Reduce Lab Turnaround Time Without New Analyzers: Operations First

The fastest way to reduce lab turnaround time is to standardize the testing process, fix pre-analytic bottlenecks, and then apply automation and measurement on top of that stable foundation. Pre-analytic fixes, smarter analyzer routing, Lean improvement events, and consistent KPI tracking tend to produce the largest gains. Studies report meaningful reductions, sometimes more than half of total turnaround time, once these steps are in place. The first move is simple: measure your current baseline before changing anything.

TL;DR:

• Standardizing workflows and fixing pre-analytic bottlenecks can cut overall turnaround times by more than half, often saving hours in the process.
• Implementing bedside barcode labeling, STAT routing, and adjusting courier schedules can produce rapid early improvements with minimal investment.
• Combining process improvements like Lean events with automation yields the most significant reductions, with some studies showing over 70% TAT decrease.
• Measurement of median turnaround time and process variability must be segmented by test type and specimen origin to accurately track improvements.
• Leadership commitment and continuous process control are crucial, as equipment upgrades alone do not sustain faster results without ongoing staff training and motivation.

Where to start: a prioritized quick-start checklist

A lab manager does not need a six-month plan to begin. The order below reflects what tends to produce results fastest, from cheapest to most involved.

1. Measure your baseline TAT this week, broken down by test type and specimen origin.
2. Require bedside barcode labeling at the point of collection to cut relabeling and rework.
3. Prioritize STAT routing so urgent samples never sit in a general queue.
4. Adjust courier pickup cadence to match peak order volume rather than a fixed schedule.
5. Add centrifugation at accessioning so samples are prepped the moment they arrive.
6. Balance analyzer load using LIS quota tools instead of adding equipment by default.
7. Schedule a short Kaizen event once the workflow is stable, not before.
8. Build a pilot business case for automation or AI tools only after standard work exists.

Involve your laboratory director, informatics team, nursing leadership, and courier service from day one. Track one KPI, median turnaround time for your highest-volume test, before adding a second metric.

Pro Tip: Pick the single test type that generates the most clinician complaints and fix its workflow first. A visible early win builds the support you will need for later, bigger changes.

Fixing delays before testing even begins

Most turnaround problems start before a sample ever reaches an analyzer. The pre-analytic phase, covering order entry, collection, labeling, transport, and accessioning, is where small process failures compound into hours of lost time. The fix begins with breaking this phase into measurable steps and capturing a timestamp at each one: order placed, sample collected, sample received, sample prepped.

Order clarity matters more than most managers expect. Computerized provider order entry (CPOE) systems reduce ambiguous or incomplete orders that otherwise trigger phone calls and delays, and AHRQ’s reported CPOE project documented a 54.5% drop in lab TAT after implementation, with median turnaround falling from 142 to 65 minutes.

Labeling errors are one of the most preventable sources of rework. Bedside barcode labeling, paired with standardized specimen labeling practices, cuts mislabeling and the relabeling cycles that push samples to the back of the queue.

Transport deserves the same scrutiny as testing itself. Consider these adjustments:

• Increase courier pickup frequency during known peak order windows rather than relying on a fixed schedule.
• Use dedicated priority bags or lanes for STAT specimens so they bypass routine batching.
• Weigh pneumatic tube systems carefully: they speed transport but can damage certain specimen types if not validated for your test menu.
• Accession specimens the moment they arrive instead of batching accessioning at set intervals.
• Centrifuge at accessioning rather than waiting for a separate prep step.

A preanalytic AI quality program has been linked to cutting 60 to 70% of errors tied to collection, labeling, and transport, a meaningful reduction given how often these errors force recollection and restart the clock entirely.

CDC’s Laboratory Quality Management System guidance treats timeliness as a core quality dimension alongside accuracy, and ties it directly to process control and equipment maintenance, not just staffing levels.

Speeding up the analytic phase without just buying more equipment

Once samples arrive in good condition, the next bottleneck is usually capacity and routing, not raw instrument speed. Labs often assume the answer is another analyzer. In practice, smarter distribution of existing capacity closes much of the gap for less money and less disruption.

• Compare the cost of adding analyzer capacity against the cost of better load-balancing software before committing to new hardware.
• Introduce targeted automation, such as decappers, sample loaders, or vendor automation modules, only after the surrounding workflow is standardized.
• Use real-time LIS dashboards to flag delayed samples and keep analyzer quotas balanced across shifts, similar to AU5800 quota-monitoring approaches used in high-volume chemistry labs.
• Align staffing patterns to known analyzer peak-load periods rather than spreading staff evenly across the day.
• Run brief daily huddles, five to ten minutes, so technologists can reprioritize samples as urgent orders come in.

Staffing flexibility matters as much as equipment here. A lab that schedules its strongest technologists during the 10 a.m. to 2 p.m. order surge will often outperform one that adds a second analyzer but keeps a flat staffing model.

Pro Tip: Before buying automation, ask whether your current bottleneck is truly analyzer throughput or just poor visibility into which samples are waiting and why.

Closing the gap between result availability and result delivery

A result can sit, fully analyzed and correct, for far longer than it should before a clinician ever sees it. This is the post-analytic phase, and it is where earlier analytic gains either translate into faster reported results or quietly disappear into a review queue.

1. Build autovalidation rules for normal or negative results, with clear safety thresholds and a full audit trail for anything that bypasses manual review.
2. Set defined result-review windows and role-based queues so pathologist or technologist sign-off does not depend on who happens to be free.
3. Test LIS-to-EHR integration regularly and remove manual sign-off steps wherever clinical safety allows it.
4. Streamline clinician result queries so a question about one value does not reopen and delay an entire report.

The AHRQ diagnostic toolkit notes that teams frequently misidentify where their real bottleneck sits. Analytic time often looks reasonable, while post-analytic communication, the gap between a verified result and a clinician actually seeing it, causes the delay patients and providers actually notice. Measuring the full cycle, not just the analytic middle, is the only way to catch this.

Why Lean and Kaizen events make automation actually pay off

Buying automation without fixing the surrounding process is one of the most common ways labs waste capital. Lean methods, value-stream mapping, 5S organization, one-piece flow, and short continuous improvement events (CIEs or Kaizen events), exist specifically to find and remove the waste that automation would otherwise just move faster.

A short Kaizen event follows a predictable structure:

• Define the scope narrowly: one test type or one workflow segment, not the entire lab.
• Capture baseline metrics before the event, not from memory.
• Run rapid PDSA (plan-do-study-act) cycles over two to five days.
• Hold daily one-hour pre-shift huddles to adjust based on what the previous day showed.

The evidence for pairing Lean with automation is substantial. A peer-reviewed conversion study of a microbiology lab moving to total laboratory automation found that median urine culture turnaround time dropped from 73.7 hours to 40.0 hours, and automation alone accounted for only 37.2% to 75.8% of that reduction depending on sample type. The remainder came directly from Lean continuous improvement events run alongside the automation rollout. Broader reviews of Lean Six Sigma in clinical laboratories report similarly large effects, with some included studies showing total TAT reductions above 70%.

The common pitfall is automating a process nobody has standardized yet. Inconsistent pre-automation workflows get amplified, not fixed, by new machines, and labs that skip planning for maintenance contracts and spare parts often lose their early gains within a year.

What automation and AI can realistically do for turnaround time

Automation and AI tools are genuinely useful, but the evidence points to a specific condition for their benefit: they help most when workflow changes accompany them, not when they are bolted onto an unchanged process.

A dual-site study published in the Journal of Clinical Microbiology found that AI-assisted culture interpretation reduced time-to-result-reporting, but the size of that reduction depended heavily on what else changed. Sites that paired AI with automated result release saw reductions of roughly 1.3 hours, while sites that also adjusted broader workflow processes saw reductions closer to 5.3 hours. Standalone AI, without any change to release rules or review queues, did not reliably shorten the time a clinician actually waited for a result.

AI tools speed the availability of interpretable results, but that gain reaches the clinician only if the lab has a process designed to release results earlier.

When piloting automation or AI tools, a few design choices make or break the business case:

• Choose one high-volume, well-understood test type for the pilot rather than spreading effort across the menu.
• Set a measurable target before starting (for example, a specific drop in median TAT or a rise in percentage within target window).
• Predefine the rules for automated result release so the pilot tests the full workflow, not just the software.
• Calculate total cost of ownership, including consumables, validation time, downtime risk, and service contracts, before comparing vendors.

Map your current-state workflow before introducing any new tool. A tool layered onto a disorganized process inherits that disorganization, and proving value on one workflow before scaling protects both the budget and the credibility of the next request.

Measuring turnaround time the right way

You cannot improve what you have not defined consistently. “Turnaround time” means different things depending on where the clock starts: order-to-result, collection-to-result, and receipt-to-final-result are all legitimate definitions, but mixing them across departments makes dashboards meaningless. Pick one primary definition for public reporting and use it everywhere.

A workable KPI set includes:

• Median TAT for your primary definition, plus the percentage of results falling within your target window.
• Interquartile range (IQR), which reveals variability that an average alone hides.
• Samples processed per FTE per day, a rough proxy for staffing adequacy.
• Rerun rate and percentage of results autovalidated without manual review.

Segment every one of these by test type, specimen origin (emergency department, inpatient, outpatient), and urgency. A STAT potassium and a routine lipid panel should never share the same target window or the same chart.

Run charts and control charts, reviewed in a weekly huddle, turn these numbers into decisions rather than archived reports. A sustained shift outside normal variation is the trigger for your next Kaizen event, not a guess.

A staged roadmap from diagnosis to scale

Treat turnaround improvement as a staged project, not a single initiative.

1. Stage 0 (weeks 1 to 2): Measure your true baseline and align stakeholders on one workflow to pilot.
2. Stage 1 (days 30 to 60): Run the pilot against a predefined KPI target, such as a specific drop in median TAT or a rise in percentage within target window, with no loss of result quality.
3. Stage 2 (post-pilot): Build training programs, maintenance and spare-parts plans, service contract terms, and any required regulatory validation before scaling.
4. Stage 3 (ongoing): Build your ROI case to include operational savings, staff reallocation, and softer benefits like inspection readiness, reviewed at each quarterly check-in.

For a deeper look at how process and technology changes work together in smaller practices, see this guide to lab testing optimization for single-specialty practices.

Pro Tip: Protect your pilot’s success criteria in writing before you start. It is much harder to redefine “success” honestly once the results are in front of leadership.

How KoHealth Labs supports faster, more reliable results

A full-service diagnostic laboratory built around the same principles described above offers fast turnaround backed by a standardized process, not just equipment. Such services typically include specimen pickup and medical courier coordination, LIS and EHR integration, molecular and PCR testing, and dedicated provider onboarding designed to reduce the handoff friction that so often delays results.

In practice, this means defined courier pickup windows matched to your order volume, custom STAT routing rules built into intake, and electronic result delivery that avoids manual re-entry on either side. Practices use KoHealth Labs either as their primary laboratory or as a supplemental partner when they need expanded testing capacity or faster support than their current lab can offer.

Case studies worth knowing: automation, Lean, and CPOE together

The strongest published evidence for turnaround improvement comes from studies that combined more than one intervention, not from automation or process change alone.

The microbiology lab conversion study referenced earlier remains the clearest example. The lab moved to total laboratory automation and ran continuous improvement events in parallel. Median urine culture TAT for positive results dropped from 73.7 hours to 40.0 hours, and the study’s breakdown showed automation accounted for only part of the drop, while continuous improvement events (CIEs) contributed significantly to the remainder depending on specimen type. Productivity per FTE rose as well, a detail that matters for the staffing conversations every lab manager eventually has with finance.

CPOE implementation tells a similar story from a different angle. AHRQ’s reported project found lab TAT fell substantially, with median turnaround time decreasing by more than half, after standardized electronic ordering replaced handwritten or verbal orders. That gain came entirely from the pre-analytic side, before a single sample reached an analyzer.

The pattern across both studies is consistent: the biggest reported reductions came from combining a process change (Lean events or standardized ordering) with a technical one (automation or electronic systems). Neither alone produced results as large as the two together, which is the core argument for sequencing process fixes before or alongside any technology purchase.

How AI changes turnaround, and where it does not

AI tools are increasingly marketed as a turnaround fix on their own, but the evidence suggests a more specific role. The Journal of Clinical Microbiology study on AI-assisted culture interpretation found that reductions in time-to-result-reporting ranged widely, from about 1.3 hours at sites using automated release alone to about 5.3 hours at sites that also adjusted broader workflow processes.

That gap is the point. AI can interpret a culture or flag an abnormal result faster than a technologist working through a queue manually, but that speed only reaches a clinician if the lab’s release rules let it. A result that is “ready” internally at 2:00 p.m. but waits in a manual review queue until 6:00 p.m. has gained nothing from the AI step.

This means an AI pilot should never be evaluated purely on internal processing speed. The metric that matters is reported turnaround time, measured from order to clinician-visible result, and that metric only improves when autovalidation rules, review queues, and release policies are redesigned to match the AI tool’s actual speed. Labs that skip this step often report disappointing pilot results that have little to do with the AI itself and everything to do with an unchanged release process sitting downstream of it.

The usual culprits behind slow turnaround times

Most turnaround problems trace back to a short list of repeat offenders, and they rarely involve the analyzer itself.

Mislabeled or mislabeled-and-recollected specimens top the list, since a recollection restarts the entire clock from zero. Incomplete or unclear orders, the exact problem CPOE systems are designed to solve, generate phone calls and clarification delays before testing can even begin. Batch-based transport and accessioning, where samples wait for a scheduled pickup or a scheduled prep window rather than moving as they arrive, adds hours that have nothing to do with analytic capacity.

On the analytic side, uneven load distribution across analyzers causes some instruments to run a backlog while others sit underused, a visibility problem more than a capacity problem. Staffing mismatches, where shift coverage does not track order volume peaks, compound this further.

Post-analytically, manual sign-off queues and result-query cycles, where a clinician’s question reopens a finalized report, are frequently the largest source of patient-facing delay even when the analytic phase performed well. CDC’s quality management guidance frames timeliness as inseparable from process control and equipment maintenance, which is why a single broken handoff step can undo gains made everywhere else in the workflow.

Staffing strategies that actually move the needle

Staffing decisions affect turnaround time as much as any piece of equipment, and the fix is rarely “hire more people.” Matching shift coverage to known order-volume peaks, rather than spreading staff evenly across a 24-hour schedule, closes gaps that a flat staffing model leaves open.

Cross-training technologists across test sections allows a lab to shift coverage toward whichever queue is backing up on a given shift, instead of leaving one section overloaded while another is idle. Brief daily huddles, lasting five to ten minutes at shift change, give staff a chance to flag which samples need priority before a backlog forms rather than after.

Workload visibility tools matter here too. A technologist who can see analyzer quotas and queue depth in real time can self-correct priorities without waiting for a supervisor to notice a problem. This is the staffing equivalent of the LIS dashboards discussed earlier in the analytic phase: the goal is giving frontline staff the information to act, not just the instruction to work faster.

Finally, protect staff time for the Kaizen events and training sessions that sustain these gains. A lab that treats improvement work as something squeezed into already-full shifts will see initial wins erode within a few months.

Why leadership commitment matters more than any gadget

The labs that sustain faster turnaround are rarely the ones with the newest analyzer. They are the ones where leadership backs a pilot with real data, lets a small early win build momentum, and keeps investing in staff training and daily huddles long after the initial project ends. Measurement and continuous improvement, not equipment, are the actual engines of faster results. Gadgets amplify whatever process already exists, good or bad.

— Kohealth Labs

How KoHealth Labs can help you shorten turnaround

If your team has standardized the workflow and is ready for a laboratory partner that executes on it, KoHealth Labs offers specimen pickup on defined windows, LIS and EHR integration, and rapid molecular and PCR testing built to support the exact process improvements covered in this guide.

Many practices use KoHealth Labs as their primary lab, while others bring us in as a supplemental partner for faster results or expanded testing capacity alongside an existing lab relationship. To see how onboarding and specimen pickup work in practice, visit our pathology laboratory services page or review how our integration process works to request a pilot for your practice.

Sources

• Conversion of a classical microbiology laboratory to a total automation laboratory enhanced by the application of lean principles
• Improving turnaround times with artificial intelligence in microbiology | Journal of Clinical Microbiology
• Laboratory Quality Management System (CDC guidance)
• Lean six sigma methodologies improve clinical laboratory efficiency and reduce turnaround times

FAQ

How do you reduce lab turnaround time effectively?

Start by standardizing the pre-analytic process, order entry, labeling, and transport, since that phase causes most avoidable delay. Then apply targeted automation and Lean continuous improvement events, which together produced reductions from 73.7 to 40.0 hours in a published microbiology conversion study.

What does it mean to reduce turnaround time?

Reducing turnaround time means shortening the interval between a specific starting point, typically order placement or specimen collection, and the moment a final, clinician-visible result is available. The exact definition matters because order-to-result and receipt-to-final-result measure different things and should not be mixed on the same dashboard.

What is a normal turnaround time for laboratory results?

Normal turnaround time varies widely by test type, urgency, and lab, which is why there is no single universal benchmark. Labs instead set internal target windows by test category and track the percentage of results falling within that window as their primary performance measure.

What is the typical turnaround time for laboratory tests?

Typical turnaround time depends heavily on the test: routine chemistry panels often complete far faster than molecular or pathology-based testing, which involves longer analytic and review steps. Rather than citing one figure, labs track median TAT and interquartile range by test type to understand their own typical performance.